Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that the Analyst/ Institutional Investor Meetings with the Company held on 15th November 2021 with Pictet Asset Management UK.
The above information is a part of company’s filings submitted to BSE.